# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-069831
Filing Date
2025-05-13
Accepted
2025-05-13 08:30:21
Documents
67
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | ck0001991792-20250331.htm iXBRL | 10-Q | 1541075
2 | EX-10.1 | ck0001991792-ex10_1.htm | EX-10.1 | 227634
3 | EX-31.1 | ck0001991792-ex31_1.htm | EX-31.1 | 16641
4 | EX-31.2 | ck0001991792-ex31_2.htm | EX-31.2 | 16429
5 | EX-32.1 | ck0001991792-ex32_1.htm | EX-32.1 | 10740
6 | EX-32.2 | ck0001991792-ex32_2.htm | EX-32.2 | 10815
| Complete submission text file | 0000950170-25-069831.txt |  | 6782734

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | ck0001991792-20250331.xsd | EX-101.SCH | 1074460
70 | EXTRACTED XBRL INSTANCE DOCUMENT | ck0001991792-20250331_htm.xml | XML | 945027

Mailing Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 (949) 419-6203
CG Oncology, Inc. (Filer) CIK: 0001991792 (see all company filings)

EIN.: 371611499 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41925 | Film No.: 25937347
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)